HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma.

MLA

Bacigalupa, Zachary A., et al. “HIF-2α Expression and Metabolic Signaling Require ACSS2 in Clear Cell Renal Cell Carcinoma.” The Journal of Clinical Investigation, vol. 134, no. 12, June 2024. EBSCOhost, https://doi.org/10.1172/JCI164249.

APA

Bacigalupa, Z. A., Arner, E. N., Vlach, L. M., Wolf, M. M., Brown, W. A., Krystofiak, E. S., Ye, X., Hongo, R. A., Landis, M., Amason, E. K., Beckermann, K. E., Rathmell, W. K., & Rathmell, J. C. (2024). HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma. The Journal of Clinical Investigation, 134(12). https://doi.org/10.1172/JCI164249

Chicago

Bacigalupa, Zachary A, Emily N Arner, Logan M Vlach, Melissa M Wolf, Whitney A Brown, Evan S Krystofiak, Xiang Ye, et al. 2024. “HIF-2α Expression and Metabolic Signaling Require ACSS2 in Clear Cell Renal Cell Carcinoma.” The Journal of Clinical Investigation 134 (12). doi:10.1172/JCI164249.